martes, 6 de octubre de 2026
BuscarExplore
Via News Knowledge File

Dow Jones Industrial Average

organization80% conf.·synced Aug 13, 2026

US stock market index

49
sourced metrics
68
relationships
2
stated objectives
5
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Monthly Return
0percent
Nov 30, 2026⚠ sources conflictsource
Distance From Record Close
3percent
Apr 15, 2026source
Year To Date Return
0.3percent
Apr 10, 2026source
Daily Return
0.58percent
Apr 10, 2026source
Index Level
47909.92points
Apr 8, 2026source
Daily Change
-0.13percent
Apr 3, 2026source
Daily Change Percent
0.48percent
Apr 2, 2026source
Daily Change Points
1000index_points
Mar 31, 2026source
Correction Depth
-10percent
Mar 28, 2026source
Ytd Performance
-6.0percent
Mar 27, 2026source
Weekly Performance
-1.7percent
Mar 27, 2026source
Drawdown From Peak
-10percent
Mar 27, 2026source
Drawdown From High
7.9percent
Mar 27, 2026source
Index Value
-0.81percent
Mar 27, 2026source
Percent Change
-1.0percent
Mar 27, 2026source
Decline Since Iran War
-7percent
Mar 27, 2026source
Closing Price
45960.11points
Mar 26, 2026source
Drawdown From Ath
-7.9percent
Mar 26, 2026source

Stated objectives

Reach 50,000 points

source
target: 50000 stated

Reach 50,000 milestone

source
target: 50000 points stated

Relationship graph · 68 connections

Competes with
16
Covered by
11
located in
11
subsidiary of
8
regulates
5
component of
5
licensed from
2
Member of
2

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com